MedPath

A CLINICAL STUDY OF COMBINED EFFECT OF KARPASASTHYADI NASAL DROPS AND MASHA ATHMAGUPTADI DECOCTION ORALLY IN THE MANAGEMENT OF PAKSHAGATA(CEREBRO VASCULAR ACCIDENT-INFARCT)

Phase 2
Conditions
Health Condition 1: G819- Hemiplegia, unspecified
Registration Number
CTRI/2024/08/072082
Lead Sponsor
Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital ,Hassan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects who are conscious and oriented – Glasgow Coma Scale greater than 8

2.Subjects aged between 30 to 65 years

3.Subjects irrespective of gender ,creed and caste

4.Subjects fit for nasya karma

5.Subjects who are ready to participate and sign the informed consent form

Exclusion Criteria

1.Diagnosed cases of intracranial hemorrhage, intracranial space occupying lesion, Congenital defects, carcinoma, Intra cranial infections

2.Subjects with uncontrolled diabetes mellitus (HbA1c greater than 8 mg/dl) and uncontrolled hypertension (greater than 160/100)

3.Pregnant women

4.Lactating mother

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Chesta nivruthi of ardhakaaya (loss of movement) <br/ ><br>2.Ruja of ardhakaaya(difficulty in speech) <br/ ><br>3.Eeshath chethana(sensory deficiet) <br/ ><br>Timepoint: 15 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.National Institute Of Health (NIH)Stroke Scale <br/ ><br>2.Medical Research Council (MRC)Scale for Muscle strengthTimepoint: 15 days
© Copyright 2025. All Rights Reserved by MedPath